TWST Twist Bioscience Corporation
Healthcare$64.59+0.00%OpenMarket Cap: $4.02B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
8.21
P/S
9.21
EV/EBITDA
-64.32
DCF Value
$-61.29
FCF Yield
-2.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
52.1%
Operating Margin
-33.9%
Net Margin
-19.8%
ROE
-17.5%
ROA
-12.0%
ROIC
-24.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 null | $110.7M | 51.6% | $-45.9M | $-44.0M | $— | — |
| Q1 null | $103.7M | 52.0% | $-32.9M | $-30.5M | $— | — |
| Q4 null | $99.0M | 51.3% | $-29.9M | $-27.1M | $— | — |
| FY null | $376.6M | 50.7% | $-136.3M | $-77.7M | $— | — |
| Q3 null | $96.1M | 53.4% | $-30.1M | $20.4M | $— | — |
| Q2 null | $92.8M | 49.6% | $-41.6M | $-39.3M | $— | — |
| Q1 null | $88.7M | 48.3% | $-34.6M | $-31.6M | $— | — |
| Q4 null | $84.7M | 45.1% | $-36.0M | $-34.7M | $— | — |
| FY null | $313.0M | 42.6% | $-220.8M | $-208.7M | $— | — |
| Q3 null | $81.5M | 43.3% | $-88.9M | $-85.6M | $— | — |
| Q2 null | $75.3M | 41.0% | $-48.9M | $-45.5M | $— | — |
| Q1 2024 | $71.5M | 40.5% | $-47.0M | $-43.0M | $-0.75 | — |